RecruitingNCT06378359

Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients


Sponsor

University of Minnesota

Enrollment

250 participants

Start Date

Jan 29, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of the study is to determine the effectiveness, safety, and health-care utilization and costs of a preoperative Staphylococcus aureus (SA) screening and decolonization bundle, (5 days of nasal mupirocin ointment, chlorhexidine gluconate (CHG) body wash, and CHG mouth rinse), in eradicating SA carriage compared to other SA decolonization approaches. The study will conduct a single center pilot trial to compare efficacy of different SA decolonization approaches in pre-surgical patients, in eradicating SA carriage, after obtaining informed consent. The study will compare four different approaches, Arm 1) screen for SA carriage and using the three-drug decolonization bundle for 5 days among patients with SA colonization, non SA carriers in this arm will get two pre-op showers with CHG soap, Arm 2) all participants receive the three drug decolonization bundle, Arm 3) all receive pre-op nasal povidone iodine the day of surgery plus two pre-op showers with CHG soap, and Arm 4) all receive nasal alcohol gel the day of surgery plus two pre op showers with CHG soap. The primary efficacy outcome will be eradication of SA colonization at all 5 body sites. Secondary outcomes will be SA surgical site infections (SSIs), all SSIs, and SA healthcare associated infections (HAIs). The study will also compare eradication of SA from each of the 5 body sites as a secondary outcome.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Eligible participanst are outpatients in orthopedic, urology, neuro, otolaryngology, plastic and general surgery and OB/GYN clinics who are scheduled to undergo surgery at participating trial sites.
  • Anticipated surgery ≥ 10 days after the date of enrollment, to allow time for completion of baseline cultures and the decolonization protocol.
  • Age ≥ 18 years
  • Ability to complete the decolonization protocol pre-operatively as an outpatient.
  • No antibiotic therapy at the time of, or seven days prior to, baseline cultures, and no subsequent antibiotic therapy prior to the surgical procedure. Standard pre-op antibiotic prophylaxis given.
  • Patients are having skin incisions as part of their scheduled surgical procedure.

Exclusion Criteria2

  • Inability to give informed consent
  • Surgery anticipated \<10 days after the baseline cultures

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERScreening and decolonization for SA carriers with the 3 drug bundle

nasal mupirocin, chlorhexidine gluconate (CHG) mouth rinse and CHG soap showers x 5 days and non-SA carriers receive 2 CHG pre-op showers

OTHERNo screening for SA

All receive the 3 drug bundle, Nasal mupirocin, chlorhexidine gluconate (CHG) mouth rinse, and CHG body wash

OTHERno screening

giving pre-surgical patients the three drug decolonization bundle without screening

OTHERNasal povidone-iodine on surgery day plus 2 CHG pre-op showers without screening.

Nasal povidone-iodine on surgery day plus 2 CHG pre-op showers without screening.

OTHERNasal alcohol gel on surgery day plus 2 CHG pre-op showers without screening

Nasal alcohol gel on surgery day plus 2 CHG pre-op showers without screening


Locations(1)

University of Minnesota Medical Center and Clinics

Minneapolis, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06378359


Related Trials